Daicel Corporation logo

Daicel Corporation

4202.T

JPXBasic MaterialsChemicals - Specialty

Latest quote

¥1,466.5

+¥1.00 · +0.07%

Aug 24, 1:22 PM JST

4202.T company overview

Regular session · JST · Market data may be delayed.

Company profile

Company website

Daicel Corporation, a Japanese enterprise founded in Osaka in 1919, conducts its business operations across Japan, Asia, North America, and Europe. The company is a key producer and distributor of a broad array of products, including cellulosic derivatives, organic chemicals, diverse plastics, and pyrotechnic devices. Its extensive activities are organized into distinct segments: Medical/Healthcare, Smart, Safety, Materials, Engineering Plastics, and other specialized areas. In the Medical/Healthcare sector, Daicel supplies various cosmetic components such as 1,3-Butylene glycol, polyglycerin, and thickeners, in addition to natural health food ingredients and dietary supplements. For the pharmaceutical industry, it provides specialized chiral and achiral columns, a variety of chiral and bio reagents, and DNA/RNA-based probes, supported by comprehensive analytical, purification, synthesis, formulation, and specialized analytical tool services. The "Smart" segment focuses on advanced materials for the electronics industry, offering triacetylcellulose and films for display technologies, solvents for electronic applications, polymers for resist processes, and cleaning agents for semiconductors. Moreover, Daicel contributes to visualization technologies with its optical components, lens units, silver nanoparticle inks, and organic semiconductor devices. Within the Safety domain, the company manufactures inflators for vehicle airbags and pyro-fuses, alongside safety mechanisms for non-automotive products. Daicel is also a significant supplier of foundational chemicals and raw materials, including acetic acid and its derivatives, cellulose acetate, and acetate tow for resins, inks, and paint solvents. It further develops specialty chemicals such as cycloaliphatic epoxies, caprolactone, ketene derivatives, and alkylamines, which are vital for electrical materials and coatings. For the Engineering Plastics segment, Daicel delivers a wide selection of plastic solutions, encompassing engineering plastics, plastic compound products, functional sheets, molded trays, and packaging films. Beyond these core offerings, the company also produces water treatment systems and diffusers tailored for diverse industrial requirements. Daicel's comprehensive portfolio plays a crucial role in various sectors, including transportation, electronics, medical care, personal care, daily life, and environmental and energy applications. The company, which was initially named Daicel Chemical Industries, Ltd., officially adopted its current name, Daicel Corporation, in October 2011.

Industry
Chemicals - Specialty
Sector
Basic Materials
Headquarters
JP
CEO
Yasuhiro Sakaki
Listed since
Jan 1, 2001
Employees
11,034

Market position

Day range

Current ¥1,466.5

52-week range

Current ¥1,466.5

Open
¥1,468
Previous close
¥1,465.5
Volume
438.7K
0.3× average
Average volume
1.45M
Average daily volume
Market cap
374.53B JPY
Beta
0.55
Market reference 1
50-day average
¥1,417.14
+3.48% above average
200-day average
¥1,371.19
+6.95% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
557.44B JPY
P/E (TTM)
37.5×
P/B (TTM)
1.02×
P/S (TTM)
0.63×
EV / EBITDA
7.67×
Earnings yield
3.16%
Free cash flow yield
0.78%
Dividend yield
4.09%

Profitability & efficiency

Gross margin
24.99%
Operating margin
7.27%
Net margin
1.67%
Return on equity
2.86%
Return on assets
1.22%
Return on invested capital
2.63%

Financial health

Debt / equity
0.84×
Current ratio
2.04×
Altman Z-score
1.91
Piotroski F-score
4 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends33%21%10%-1%Gross margin, FY2022: 29.85%Gross margin, FY2023: 27.33%Gross margin, FY2024: 28.74%Gross margin, FY2025: 28.27%Gross margin, FY2026: 25.24%Operating margin, FY2022: 10.83%Operating margin, FY2023: 8.83%Operating margin, FY2024: 11.18%Operating margin, FY2025: 10.40%Operating margin, FY2026: 7.26%Net margin, FY2022: 6.68%Net margin, FY2023: 7.56%Net margin, FY2024: 10.01%Net margin, FY2025: 8.44%Net margin, FY2026: 1.76%FY2022FY2023FY2024FY2025FY2026
Gross margin FY2022 29.85%. Gross margin FY2023 27.33%. Gross margin FY2024 28.74%. Gross margin FY2025 28.27%. Gross margin FY2026 25.24%. Operating margin FY2022 10.83%. Operating margin FY2023 8.83%. Operating margin FY2024 11.18%. Operating margin FY2025 10.40%. Operating margin FY2026 7.26%. Net margin FY2022 6.68%. Net margin FY2023 7.56%. Net margin FY2024 10.01%. Net margin FY2025 8.44%. Net margin FY2026 1.76%.

Income trends

Revenue

579.63B JPY-1.18%

Operating income

42.07B JPY-31.05%

Net income

10.18B JPY-79.42%
Income trends across reported periods644.17B JPY413.63B JPY183.09B JPY−47.45B JPYRevenue, FY2022: 467.94B JPYRevenue, FY2023: 538.03B JPYRevenue, FY2024: 558.06B JPYRevenue, FY2025: 586.53B JPYRevenue, FY2026: 579.63B JPYOperating income, FY2022: 50.7B JPYOperating income, FY2023: 47.51B JPYOperating income, FY2024: 62.39B JPYOperating income, FY2025: 61.01B JPYOperating income, FY2026: 42.07B JPYNet income, FY2022: 31.25B JPYNet income, FY2023: 40.68B JPYNet income, FY2024: 55.84B JPYNet income, FY2025: 49.48B JPYNet income, FY2026: 10.18B JPYFY2022FY2023FY2024FY2025FY2026
Revenue FY2022 467.94B JPY. Revenue FY2023 538.03B JPY. Revenue FY2024 558.06B JPY. Revenue FY2025 586.53B JPY. Revenue FY2026 579.63B JPY. Operating income FY2022 50.7B JPY. Operating income FY2023 47.51B JPY. Operating income FY2024 62.39B JPY. Operating income FY2025 61.01B JPY. Operating income FY2026 42.07B JPY. Net income FY2022 31.25B JPY. Net income FY2023 40.68B JPY. Net income FY2024 55.84B JPY. Net income FY2025 49.48B JPY. Net income FY2026 10.18B JPY.
Metric (JPY)FY2026FY2025FY2024FY2023FY2022
Revenue579.63B JPY586.53B JPY558.06B JPY538.03B JPY467.94B JPY
Cost of goods sold433.34B JPY420.69B JPY397.67B JPY390.98B JPY328.26B JPY
Gross profit146.29B JPY165.84B JPY160.39B JPY147.04B JPY139.68B JPY
Research and development25.93B JPY23.39B JPY21.88B JPY20.74B JPY
Selling, general, and administrative104.22B JPY78.9B JPY74.6B JPY77.66B JPY68.24B JPY
Operating expenses104.22B JPY104.83B JPY97.99B JPY99.54B JPY88.98B JPY
Interest income816M JPY1.21B JPY1.57B JPY697M JPY236M JPY
Interest expense3.2B JPY1.98B JPY1.67B JPY1.43B JPY1.36B JPY
Depreciation and amortization43.34B JPY41.37B JPY33.7B JPY31.58B JPY28.2B JPY
Operating income42.07B JPY61.01B JPY62.39B JPY47.51B JPY50.7B JPY
Net income10.18B JPY49.48B JPY55.84B JPY40.68B JPY31.25B JPY

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
55%
6 beats, 5 misses, 0 met estimates
Average EPS surprise
-26.72%
11 comparable reports
Latest EPS result
36.65
Estimate 21.46 · Beat by 70.78%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates76.9214.92-47.07-109.07Q1 '25MissQ2 '25MissQ3 '25BeatQ4 '25MissQ1 '26BeatQ2 '26MissQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Feb 5, 2025: actual 44.12, estimate 57, surprise -22.60%, Miss. Q2 2025, reported May 13, 2025: actual 21.14, estimate 42.57, surprise -50.34%, Miss. Q3 2025, reported Aug 1, 2025: actual 36.29, estimate 34.92, surprise +3.92%, Beat. Q4 2025, reported Nov 6, 2025: actual 34.61, estimate 58.9, surprise -41.24%, Miss. Q1 2026, reported Feb 5, 2026: actual 64.09, estimate 50.21, surprise +27.64%, Beat. Q2 2026, reported May 12, 2026: actual -96.24, estimate 51.88, surprise -285.51%, Miss. Q3 2026, reported Jul 31, 2026: actual 36.65, estimate 21.46, surprise +70.78%, Beat. Q4 2026, reported Oct 29, 2026: actual —, estimate 21.88, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates165.8B154.36B142.92B131.47BQ1 '25MissQ2 '25MissQ3 '25MissQ4 '25MissQ1 '26BeatQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Feb 5, 2025: actual 142.86B JPY, estimate 154.32B JPY, surprise -7.43%, Miss. Q2 2025, reported May 13, 2025: actual 153.99B JPY, estimate 159.42B JPY, surprise -3.41%, Miss. Q3 2025, reported Aug 1, 2025: actual 139.27B JPY, estimate 145.96B JPY, surprise -4.58%, Miss. Q4 2025, reported Nov 6, 2025: actual 137.85B JPY, estimate 145.38B JPY, surprise -5.18%, Miss. Q1 2026, reported Feb 5, 2026: actual 147.71B JPY, estimate 145.79B JPY, surprise +1.31%, Beat. Q2 2026, reported May 12, 2026: actual 154.81B JPY, estimate 150.14B JPY, surprise +3.11%, Beat. Q3 2026, reported Jul 31, 2026: actual 152.38B JPY, estimate 143.04B JPY, surprise +6.53%, Beat. Q4 2026, reported Oct 29, 2026: actual —, estimate 149B JPY, surprise —, Comparison unavailable.

4202.T peers

ETFs holding 4202.T

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research 4202.T

research.disclaimer